Bringing sterile products to market is more complex than ever. CMC and outsourcing leaders are under pressure to move faster, reduce risk, secure supply and find partners who can support the full journey from clinical development to commercial manufacture. Yet for many sterile products, the path to success is challenged by process complexity, scale-up uncertainty, technology transfer risk and the need for robust fill-finish and lyophilization expertise. In this webinar, we will showcase our expanded sterile fill-finish capabilities following our latest acquisition and explain how these additions strengthen our ability to support customers across the product lifecycle. We will explore how an integrated CDMO model can provide not only technical depth in sterile manufacturing, but also the flexibility, resilience and executional strength needed to support evolving programme demands. Through two real-world case studies, we will demonstrate how we help customers de-risk critical stages of sterile product development and manufacture. The first will focus on lyophilization qualification and scale-up from clinical to commercial phase, including how we assess lyophilizer performance, map temperature in both equipment and product, evaluate sublimation behaviour and build a scalable, robust process. The second will show how a new product is integrated into a facility through a clear, structured and site-independent approach, highlighting the benefits of working with a CDMO network rather than relying on a single site. Attendees will gain practical insight into how the right sterile CDMO partner can simplify complexity, strengthen supply strategy and accelerate the path to commercialization. If you are evaluating fill-finish outsourcing options for sterile products, this session will show what to look for in a partner and how expanded capabilities can create real value across development, transfer and supply.

Key Learning Objectives

• Understand what CMC and outsourcing teams should look for in a CDMO partner for sterile fill-finish and lyophilized products.
• Learn how robust lyophilization qualification and scale-up strategies can reduce technical risk from clinical to commercial manufacture.
• Discover how a site-independent technology transfer and product integration model can improve speed, consistency and delivery.
• Explore the strategic value of accessing a network of sterile manufacturing capabilities through a single CDMO partner.

Register now to discover how to bring greater confidence, flexibility and scalability to your sterile product strategy.